Consistently, analysis of CRC patient tissues (Table S2) revealed a stage-dependent increase in dysadherin and LAMP2 expression, along with a positive correlation between the two markers (Fig. 1d, Supplementary Fig. 1f, g). This evidence concerns the gene FXYD5 and colorectal carcinoma.